Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyrazoloacridine in Metastatic Cutaneous and Ocular Melanoma
NCT00003802Phase 2Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Feb 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pyrazoloacridine in cutaneous melanoma (CM), Ocular Melanoma, sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Feb 1999; status: completed.
02
Drugs
pyrazoloacridine
03
Conditions
cutaneous melanoma (CM)Ocular Melanoma
Beyond the preview
Go deeper on NCT00003802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003802.